Currently, AdaptHealth Corp [AHCO] is trading at $10.86, up 2.65%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AHCO shares have gain 5.95% over the last week, with a monthly amount drifted -5.48%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
AdaptHealth Corp [NASDAQ: AHCO] stock has seen the most recent analyst activity on January 08, 2024, when Jefferies downgraded its rating to a Hold and also revised its price target to $8 from $14.50. Previously, BofA Securities downgraded its rating to Underperform on November 08, 2023, and dropped its price target to $6.50. On May 10, 2023, downgrade downgraded it’s rating to Hold and revised its price target to $11 on the stock. Deutsche Bank downgraded its rating to a Hold and decreased its price target to $11.30 on May 10, 2023. BofA Securities downgraded its rating to a Neutral and reduced its price target to $12 on May 09, 2023. SVB Leerink started tracking with a Outperform rating for this stock on September 27, 2021, and assigned it a price target of $30. In a note dated July 14, 2021, Robert W. Baird upgraded an Outperform rating on this stock and boosted its target price from $30 to $36.
This stock has fluctuated between a low of $6.37 and a high of $11.90 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $23.83 within the next 12 months. AdaptHealth Corp [NASDAQ: AHCO] shares were valued at $10.86 at the most recent close of the market. An investor can expect a potential return of 119.43% based on the average AHCO price forecast.
Analyzing the AHCO fundamentals
Trailing Twelve Months sales for AdaptHealth Corp [NASDAQ:AHCO] were 3.26B which represents 1.60% growth. Gross Profit Margin for this corporation currently stands at 0.15% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.21%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.45 and Total Capital is -0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.64 points at the first support level, and at 10.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.04, and for the 2nd resistance point, it is at 11.22.
Ratios To Look Out For
To put it in perspective, the Current Ratio for AdaptHealth Corp [NASDAQ:AHCO] is 1.15. In addition, the Quick Ratio stands at 0.94 and the Cash Ratio stands at 0.12. Considering the valuation of this stock, the price to sales ratio is 0.45, the price to book ratio is 0.95.
Transactions by insiders
Recent insider trading involved Rietkerk Shaw, Former Chief Operating Officer, that happened on Sep 20 ’24 when 25000.0 shares were sold. Officer, Rietkerk Shaw completed a deal on Sep 20 ’24 to buy 25000.0 shares. Meanwhile, Former Affiliate Richard A. Barasch bought 40022.0 shares on Sep 18 ’24.
